RecallRadar

FDA Drug recall D-0808-2026

Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic,…

On 2026-09-09 the FDA classified a Class II recall of Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic,… by Baxter Healthcare, citing CGMP Deviations.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0808-2026
ClassificationClass II
Statusongoing
Initiated2026-08-06
Published2026-09-09
Last updated2026-09-15 05:30 UTC
CompanyBaxter Healthcare
DistributionUS

Product

Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50.

Reason

CGMP Deviations

Identifiers

ndc0338-3410-50
ndc0338-3410-24
ndc0338-3612-50
ndc0338-3612-24
ndc0338-3814-50
ndc0338-3814-24
code_infoLot # NC193764, Exp Date: 10/18/2027; Lot # NC195232, Exp Date: 11/25/2027.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-15 05:30 UTC. Current status: ongoing.

Other recalls by Baxter Healthcare

All Baxter Healthcare recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0808-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.